ACC Regional Conferences in Japan and UAE Work to Improve Heart Health

Cardiology Magazine Image

Local learning with global experts to create connections and achieve practical solutions to improve heart health was the foundation of two collaborative regional conferences held this fall.

The ACC continued its long-term partnership with the Japanese College of Cardiology for the ACC Asia 2019 conference, held Sept. 13-14, in Nagoya, Japan, and with the Emirates Cardiac Society for the ACC Middle East Conference 2019, held Oct. 3-5. Both regional conferences have become annual events welcomed by local cardiovascular professionals as they work with ACC experts to examine evidence-based strategies, contemporary best practices and clinical decision-making to strengthen their everyday practice and return home with shared knowledge.

ACC Asia Conference 2019 was co-chaired by Aaron D. Kugelmass, MD, FACC, and Keiichi Fukuda, MD, PhD, FACC. ACC faculty, including ACC Immediate Past President C. Michael Valentine, MD, MACC; Pamela Morris, MD, FACC; Shun Kohsaka, MD, PhD, FACC; Fred Kusumoto, MD, FACC; Minoru Ono, MD, PhD; Frederick Masoudi, MD, MSPH, FACC, and ACC Chief Innovation Officer John Rumsfeld, MD, PhD, FACC, joined with local leaders to discuss advanced heart failure management, cardiovascular disease prevention in a new era of options, promoting quality care and outcomes through registries, artificial intelligence and the future of cardiology.

The winners of the top three abstracts from the ACC Asia Conference will present their work at ACC.20 Together With World Congress of Cardiology in Chicago, IL, held from March 28-30. The abstract titles are: Clinical Impact of Hemodialysis on Short-term Prognosis in Acute Heart Failure: Multi-center Registry from Tokyo Cardiovascular Care Unit Network; Irregular Protrusion is Correlated With Development of Neoatherosclerosis After New Generation Drug-Eluting Stent Implantation: Optical Coherence Tomographic Study; and Real-World Three-Year Outcome in Patients With Non-Valvular Atrial Fibrillation in the Era of Treatment With Direct Oral Anticoagulants.

ACC's Middle East Conference similarly honed in on regional best practices, and additionally tackled new approaches in primary prevention as well as the global burden of noncommunicable diseases (NCDs). The weekend event was led by conference co-chairs Dipti Itchhaporia, MD, FACC, and Abdullah Shehab, MBChB, MMed, FACC. ACC faculty, including Carolyn Y. Ho, MD, FACC, lectured on topics including the role of genetic testing in heritable cardiovascular diseases, novel risk enhancers for heart disease in women, associations between nontraumatic tooth loss and cardiovascular disease, the impact of a high-fiber diet on cardiovascular risk markers in comorbidity of hypertension and type 2 diabetes, and more.

Visit ACC.org/Asia2019 and ACC.org/MiddleEast2019 to learn more about both conferences and explore the abstracts from each conference. Missed the conference? Read the Twitter coverage at #ACCIntl.

Clinical Topics: Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Prevention, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Diet, Hypertension

Keywords: Atrial Fibrillation, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Decision Support Systems, Clinical, Tooth Loss, Cardiology, Hypertension, Heart Failure, Primary Prevention, Diet, Asia, Middle East, Japan, United Arab Emirates


< Back to Listings